Panama's Minsa Cancels BMHCA Cosmetic Registrations: What Changes

Panama now cancels cosmetic health registrations it had already approved. On June 24, 2026, the National Directorate of Pharmacy and Drugs (DNFD) of the Ministry of Health (Minsa) signed Resolution No. 098, which cancels registration 106953 of a perfume and orders all lots withdrawn from the market; Resolution No. 097, of the same date, did the same for another perfume from the same brand¹³. In Panama, the reason was a fragrance ingredient banned in cosmetics in the European Union. For physicians and aesthetic clinics, the case clarifies how cosmetic registration works, the same framework that peptide cosmetics depend on.

What Minsa cancelled and when

Resolution No. 098 appeared in Gaceta Oficial Digital No. 30567-A of July 14, 2026. It cancels registration 106953 of Britney Spears Fantasy Eau de Parfum Spray (Elizabeth Arden, Inc.), issued on January 23, 2020 and valid until January 23, 2030, and orders all distributors to withdraw the available lots immediately¹³. Resolution No. 097 cancels registration 103152 of Britney Spears Sunset Fantasy Eau de Toilette Spray, valid until March 20, 2029²³.

The second batch involved sunscreens. According to La Estrella, Resolution No. 100 of July 7, 2026 cancelled registrations 106521 and 106527 of Nivea Sun Protect & Refresh SPF 30 and SPF 50⁵. La Prensa reported that the resolutions took effect on publication in the Gaceta on Tuesday, July 21, that the registrations were issued on December 6, 2019 and expire in 2029, and that the manufacturer is Beiersdorf Manufacturing Tres Cantos, of Spain⁴. In April, La Estrella had already reported the annulment in March of three more perfumes: Montblanc Lady Emblem Elixir, Valentino Valentina and Montblanc Lady Emblem⁷.

• What is ordered: cancel the registration and withdraw all available lots; distributors have a maximum of 30 days to file the withdrawal report².
• What Minsa told the public: in July it asked people to check labels and stop using a product if BMHCA or lilial appears, and warned that products bought abroad may contain it even without a Panamanian registration⁶.
• What the sources do not say: how many units were on the market or which stores sold them³.

BMHCA: the regulatory chain that reached Panama

Resolution 098 reconstructs the chain. The European Commission, through its Safety Gate rapid alert system, published Report 2025-45 on November 6, 2025, on the withdrawal of several cosmetics containing prohibited ingredients. BMHCA (2-(4-tert-butylbenzyl) propionaldehyde) is listed in Annex II of Regulation (EC) No. 1223/2009 and is prohibited in cosmetics; the resolution also notes that the Scientific Committee on Consumer Safety included the compound in the list of prohibited substances¹.

Regulation (EU) 2021/1902 was adopted on October 29, 2021 and published on November 3, 2021; its listed entry-into-force dates are November 23, 2021 and March 1, 2022¹⁰. Telemetro summarizes Minsa's position: BMHCA is classified as carcinogenic, mutagenic or toxic to reproduction (CMR), and prolonged use could affect fertility, fetal development, or cause skin allergies⁶. This article claims no more harm than those sources state.

What cosmetic registration requires in Panama

Law 419 of 2024 requires health registration for cosmetics, and according to its text on vLex it gives the DNFD the power to issue, suspend and cancel registrations⁹. Executive Decree 27 of 2024, which implements it, sets out the regime⁸:

• Mandatory registration to import, manufacture, distribute and sell a cosmetic (art. 189), temporary, renewable and valid for five years (art. 191).
• Ingredient references recognized by the DNFD: the Personal Care Products Council, the European CosIng database, EU directives, the Central American Technical Regulation and FDA guidance (art. 203). The formula must use INCI names (art. 204).
• Post-market surveillance through label review; if there is a suspicion or a national or international risk notification, the DNFD must send the product for analysis (art. 290), and may set safety measures (art. 344).
• Traceability and liability: the registration holder and the manufacturer share liability (art. 343) and every establishment must demonstrate traceability (art. 346).

This design explains the cases: an international notification (Safety Gate) triggers local review, and a valid registration does not protect the product. The Nivea and Elizabeth Arden registrations were issued in 2019 and 2020, before the European regulation was adopted¹⁴¹⁰; in addition, article 344 lets the DNFD set safety measures⁸.

Seven months between the European alert and the resolution

Between the Safety Gate report of November 6, 2025 and Resolution 098 of June 24, 2026, about seven and a half months passed, and the Gaceta took another three weeks to publish it¹. The DNFD had digitized cosmetic registration in 2022, a process previously manual and in person¹², but cosmetovigilance depends on the alert arriving and being processed. The alert volume is huge: in 2025, 4,671 were notified in Safety Gate, 36% for cosmetics, and almost eight in ten cosmetics alerts were due to BMHCA¹¹. If the pattern continues, other products registered in Panama could be affected.

What it means for peptide cosmetics

None of the cited sources names a peptide cosmetic among those cancelled: BMHCA is an aromatic aldehyde used as a fragrance¹. The lesson is about mechanism. A cosmetic with signal, carrier or neurotransmitter-affecting peptides, categories described in the literature¹³¹⁴, needs a valid registration, a formula with INCI names, and claims that match what its formula can substantiate: article 207 prohibits claiming properties that cannot be proven, and article 208 excludes from the cosmetic category any product that promises to cure a disease or that can be ingested, inhaled or injected⁸.

The scientific base is uneven. A systematic review of peptides that stimulate the extracellular matrix found 15 clinical studies, only six with a placebo control and five double-blind, and concluded that the literature is sparse¹⁵. There are also formal safety assessments: the Cosmetic Ingredient Review panel concluded in 2025 that acetyl hexapeptide-8 is safe in cosmetics up to 0.005% and that data are insufficient above that concentration¹⁶, and in 2026 a bioinformatic framework for evaluating the safety of cosmetic peptides was proposed¹⁷. More context in peptides in cosmetics: types and evidence and SNAP-8 and cosmetic peptides.

On the broader framework, see also the registration double standard in Panamanian aesthetics and Minsa's campaign against counterfeit medicines.